| SEER cancer statistics review, 1975–2012 N Howlader, AM Noone, M Krapcho, J Garshell, N Neyman, SF Altekruse, ... National Cancer Institute, 2014 | 9920* | 2014 |
| SEER cancer statistics review, 1975–2016 N Howlader, AM Noone, M Krapcho, D Miller, A Brest, M Yu, J Ruhl, ... National Cancer Institute 1, 2019 | 1667 | 2019 |
| The impact of underreported Veterans Affairs data on national cancer statistics: analysis using population-based SEER registries N Howlader, LA Ries, DG Stinchcomb, BK Edwards Journal of the National Cancer Institute 101 (7), 533-536, 2009 | 1647 | 2009 |
| SEER cancer statistics review, 1975–2005 LAG Ries, D Melbert, M Krapcho, DG Stinchcomb, N Howlader, ... Bethesda, MD: National Cancer Institute 2999, 2008 | 1628 | 2008 |
| SEER cancer statistics review, 1975-2007 A Sf http://seer. cancer. gov/csr/1975_2007/results_merged/sect_13_leukemia. pdf, 2009 | 1578 | 2009 |
| SEER cancer statistics review 1975-2013 CS Time | 1478 | 2016 |
| Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program MJ Hayat, N Howlader, ME Reichman, BK Edwards The oncologist 12 (1), 20-37, 2007 | 1428 | 2007 |
| The decrease in breast-cancer incidence in 2003 in the United States PM Ravdin, KA Cronin, N Howlader, CD Berg, RT Chlebowski, EJ Feuer, ... New England Journal of Medicine 356 (16), 1670-1674, 2007 | 1350 | 2007 |
| US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status N Howlader, SF Altekruse, CI Li, VW Chen, CA Clarke, LAG Ries, ... Journal of the National Cancer Institute 106 (5), dju055, 2014 | 1326 | 2014 |
| Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics KA Cronin, AJ Lake, S Scott, RL Sherman, AM Noone, N Howlader, ... Cancer 124 (13), 2785-2800, 2018 | 1198 | 2018 |
| The effect of advances in lung-cancer treatment on population mortality N Howlader, G Forjaz, MJ Mooradian, R Meza, CY Kong, KA Cronin, ... New England Journal of Medicine 383 (7), 640-649, 2020 | 1131 | 2020 |
| Annual report to the nation on the status of cancer, 1975-2011, featuring incidence of breast cancer subtypes by race/ethnicity, poverty, and state BA Kohler, RL Sherman, N Howlader, A Jemal, AB Ryerson, KA Henry, ... Journal of the National Cancer Institute 107 (6), djv048, 2015 | 1091 | 2015 |
| SEER cancer statistics review, 1975–2017 N Howlader, AM Noone, M Krapcho, D Miller, A Brest, M Yu, J Ruhl, ... National Cancer Institute 4, 2020 | 958 | 2020 |
| Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs DE Rollison, N Howlader, MT Smith, SS Strom, WD Merritt, LA Ries, ... Blood, The Journal of the American Society of Hematology 112 (1), 45-52, 2008 | 855 | 2008 |
| SEER Cancer Statistics Review, 1975-2010, National Cancer Institute. Bethesda, MD N Howlader, AM Noone, M Krapcho, J Garshell, N Neyman, SF Altekruse, ... | 739 | 2013 |
| SEER Cancer Statistics Review, 1975-2013, National Cancer Institute. Bethesda, MD N Howlader, AM Noone, M Krapcho, D Miller, K Bishop, SF Altekruse, ... | 638 | 2016 |
| SEER Cancer Statistics Review, 1975-2015, National Cancer Institute. Bethesda, MD AM Noone, N Howlader, M Krapcho, D Miller, A Brest, M Yu, J Ruhl, ... | 570 | 2018 |
| Differences in breast cancer survival by molecular subtypes in the United States N Howlader, KA Cronin, AW Kurian, R Andridge Cancer Epidemiology, Biomarkers & Prevention 27 (6), 619-626, 2018 | 514 | 2018 |
| SEER cancer statistics review, 1975–2018 N Howlader, AM Noone, M Krapcho, D Miller, A Brest, M Yu, J Ruhl, ... National Cancer Institute, 1-25, 2021 | 497 | 2021 |
| Improved estimates of cancer-specific survival rates from population-based data N Howlader, LAG Ries, AB Mariotto, ME Reichman, J Ruhl, KA Cronin JNCI: Journal of the National Cancer Institute 102 (20), 1584-1598, 2010 | 488 | 2010 |
